Comparison hub

In this section, you can compare what actions the 17 pharmaceutical companies in scope are taking to limit AMR. All of the figures and analyses per Research Area from the report cards can be compared, for a maximum of three companies. For example, you can compare number of projects in the pipeline or products on the market. Or, take a look at the revenue per product or region, for each company.